Decreased Expression of T-Cell Costimulatory Molecule CD28 on CD4 and CD8 T Cells of Mexican Patients with Pulmonary Tuberculosis

Table 1

Clinical and laboratory data in patients with tuberculosis.

Patient	Age (years)	Sex	Relapses	Duration (months)	Strain	WBC (mm^3)	Lymph (%)	Mono (%)	PMN (%)
01	39	F	—	12	R	5500	20	3	77
02	49	F	—	12	S	4800	30	3	67
03	49	M	$\surd$	24	R	6900	28	1	71
04	44	M	$\surd$	22	R	13700	23	2	75
05	47	M	—	10	S	5700	24	2	74
06	64	M	$\surd$	63	R	6800	32	3	65
07	57	M	$\surd$	16	S	4200	32	1	67
08	75	M	—	12	R	6700	22	1	77
09	78	M	—	22	R	6500	24	5	71
10	30	F	$\surd$	36	R	7200	28	2	70
11	61	F	$\surd$	55	R	8000	29	5	66
12	29	F	$\surd$	12	R	10700	17	1	82
13	58	M	$\surd$	12	R	5700	42	1	57
14	58	F	—	6	S	6400	30	1	69
15	68	F	—	4	S	4100	44	0	56
16	63	M	$\surd$	36	R	6700	32	8	60
17	40	F	—	18	R	5700	34	17	49
18	71	M	$\surd$	88	R	8500	25	6	69
19	54	F	—	60	R	5600	45	10	45
20	47	M	—	2	S	3600	34	5	61
21	74	M	$\surd$	36	R	7100	33	16	51
22	66	F	—	9	ND	7200	28	2	70
23	46	M	—	12	R	6300	55	7	38

M. tuberculosis strains, resistant (R), susceptible (S), ND, not done. WBC, white blood cells; Lymph, lymphocytes; Mono, monocytes; PMN, polymorphonuclear leukocytes. Duration refers to the duration of the tuberculosis pulmonary symptoms as stated in the clinical records.